Your browser doesn't support javascript.
loading
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?
Beitinjaneh, Amer; Kaufman, Adrienne; Wang, Yucai; Jain, Preetesh; Srour, Samer A; Wang, Michael.
Affiliation
  • Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, 1121 NW 14 Street, Office 241, Miami, FL, 33136, USA. abeitinjaneh@miami.edu.
  • Kaufman A; Mayo Clinic, Phoenix, AZ, USA.
  • Wang Y; Mayo Clinic, Rochester, MN, USA.
  • Jain P; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Srour SA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang M; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Curr Treat Options Oncol ; 23(11): 1614-1625, 2022 11.
Article in En | MEDLINE | ID: mdl-36227407
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Lymphoma, Mantle-Cell / Receptors, Chimeric Antigen Type of study: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Curr Treat Options Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Lymphoma, Mantle-Cell / Receptors, Chimeric Antigen Type of study: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Curr Treat Options Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos